Safety, Tolerability, Pharmacokinetics, and Food Effects on TAC‐302 in Healthy Participants: Randomized, Double‐Blind, Placebo‐Controlled, Single‐Dose and Multiple‐Dose Studies

TAC‐302 stimulates neurite outgrowth activity and is expected to restore urinary function in patients with lower urinary tract dysfunction. We conducted 2 phase 1, randomized, placebo‐controlled studies to confirm the safety and pharmacokinetics (PK) of TAC‐302 in healthy adult Japanese male volunte...

Descripción completa

Detalles Bibliográficos
Autores principales: Sesoko, Shogo, Huang, Jinhong, Okayama, Takashige, Nishida, Erika, Miyoshi, Kazuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586813/
https://www.ncbi.nlm.nih.gov/pubmed/31970939
http://dx.doi.org/10.1002/cpdd.776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586813/
https://www.ncbi.nlm.nih.gov/pubmed/31970939
http://dx.doi.org/10.1002/cpdd.776

Ejemplares similares